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Unlike immortalized cell lines, normal human fibro- 
blasts in culture undergo replicative senescence in 
which the number of population doublings is limited. 
While fibroblasts display a variety of changes as they 
senesce in vitro, little is known about how gene expres- 
sion varies as a function of population doubling level. 
We have used differential hybridization screening to 
identify human genes that are preferentially expressed 
in senescent cells. While we found several isolates that 
were up-regulated in late-passage cells, all appeared to 
be variants of the same cDNA, which we named senes- 
cence-associated gene (SAG). Our data show that SAG 
expression is threefold higher in senescent fibroblasts 
and closely parallels the progressive slowdown in 
growth potential, but is not cell-cycle regulated. Thus, 
SAG serves as an accurate marker for fibroblast 
growth potential during replicative senescence. Fur- 
ther studies demonstrated that SAG is a novel gene ac- 
tive in nearly all tissue types tested and that it is con- 
served through evolution. DNA sequencing data indi- 
cate that SAG contains a potential DNA-binding 
domain, suggesting that SAG may function as a regula- 
tory protein. 0 1992 Academic Press, Inc. 
INTRODUCTION 
Diploid human fibroblast cells have a finite replica- 
tive life span in culture of 50 to 70 doublings and have 
been used as a model to study senescence at the cellular 
level [l-5]. While a number of morphological and physi- 
ological changes accompany replicative senescence, the 
principle observable changes are the increases in cell 
size and generation time [3-61. At the end of their life 
spans, senescent cells become postmitotic, but still re- 
tain viability for many months [6]. 
Several lines of evidence indicate that senescent cells 
express a dominant inhibitor of cell proliferation that 
may be part of the mechanism controlling the senes- 
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cence process. First, fusion experiments between sene- 
scent and dividing early-passage cells indicated that se- 
nescent cells contain a protein that is able to suppress 
DNA synthesis in the younger dividing nucleus [7-lo]. 
These studies were further supported by RNA microin- 
jection studies [ 111, which showed that poly A+ RNA 
from late-passage cells suppressed the level of DNA syn- 
thesis in early-passage fibroblasts. 
Second, fusion of normal human diploid cells with 
various immortal cell lines generated cells with a limited 
proliferative capacity [12-171, indicating that the lim- 
ited-division phenotype is dominant even over immor- 
talized cells. The same conclusion was drawn from fu- 
sion experiments between different immortal cell lines. 
When cells from two different complementation groups 
(out of four possible) were fused, the limited-division 
phenotype was seen in the hybrids of immortal cell 
lines, indicating that immortalization is a recessive trait 
and that senescence requires expression of at least four 
gene products [l&19]. In recent cell-fusion experi- 
ments, putative senescence-promoting genes have been 
localized to human chromosomes 1 [20] and 4 [21]. Fur- 
thermore, insertion of chromosome 4 induces senes- 
cence in immortalized cells of one of the four comple- 
mentation groups, but not of the other three [21]. 
The third line of evidence linking replicative senes- 
cence with dominant-acting inhibitors comes from the 
recent work with antigrowth genes. The introduction of 
expression vectors containing ~53 or retinoblastoma 
into immortalized cells with defects in one of these 
genes restores growth inhibition and replicative senes- 
cence [5, 22-261. Moreover, the retinoblastoma gene 
gains more growth-inhibitory activity in senescent fibro- 
blasts [27], again suggesting that various antigrowth 
genes play an active role in senescence. 
If cellular senescence is under the genetic control of 
growth inhibitors, it may be possible to identify novel 
genes that are up-regulated in senescent cells. Besides 
serving as markers of senescence, such genes may func- 
tion as targets for regulation or may themselves be regu- 
latory. To date, the only RNA species reported to in- 
crease in senescent fibroblasts are a histone 3 variant, 
statin, ribosomal elongation factor 1, H-ras, fibronectin, 
and several uncharacterized cDNA clones found by dif- 
ferential screening [ 28-341. It is not clear if any of these 
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genes are involved in the control of cellular senescence. 
For example, some of the genes, such as statin [32,35], 
are expressed at similar levels in both young and senes- 
cent cells made quiescent by growth in low serum media 
and thus may be regulated more by the cell cycle than by 
the stage of replicative senescence. 
In this manuscript we describe the use of differential 
screening of a senescent fibroblast cDNA library with 
32P-labeled cDNA from quiescent early- and late-pas- 
sage cells to identify genes whose expression increases 
in late-passage fibroblasts. We report the cloning and 
characterization of a novel senescence-specific cDNA 
whose mRNA level increases with cellular senescence. 
We further show that SAG expression is independent of 
the growth state in early-passage cells. These properties 
make SAG a good marker of replicative senescence and 
a potential regulatory site for the growth-inhibitory 
mechanism. 
MATERIALS AND METHODS 
Cell culture. Human diploid fibroblast MRC-5 cells were obtained 
from the NIH Aging Cell Repository at a population doubling level 
(PDL) of 15. The cells were cultured in a 1:l mixture of Dulbecco 
modified Eagle medium and Ham nutrient F-12 medium (DME/FlZ, 
Sigma, 8900) supplemented with 10% calf serum (Hazelton), 100 
units/ml penicillin, 50 pg/ml streptomycin, and 50 @g/ml neomycin. 
To subculture cells, confluent fibroblasts were washed in BSS buffer 
(15 mM Hepes, 130 mM NaCl, 5 mM KCl, 1 mM Na,PO,, 0.3% glu- 
cose) and then treated with BSS buffer containing 0.25% trypsinl 
EDTA (Sigma). The trypsin was siphoned off after 1 min and the cells 
were incubated for 2 more min at room temperature. The cells were 
then resuspended in DME/FlS medium and aliquots were counted in 
a hemocytometer before splitting them 1:4 into new flasks or plates. 
Cells were kept in an incubator humidified in the presence of 3.5% 
COz. All other cell lines were grown under similar conditions. How- 
ever, subculture ratios varied from 1:4 to l:lO, depending on the 
growth rate of the cells. To harvest the cells, they were washed with 
BSS buffer, scraped from the plates, and collected by centrifugation 
at 1500g for 5 min. 
DNA isolation, blotting, and hybridization. DNA was purified 
from nuclei as previously described [36]. The DNA was digested with 
EcoRI restriction endonuclease at 37°C for 2 h and size fractionated 
on 1.2% agarose gels before Southern blotting [37]. Blot hybridization 
to cu-32P-labeled probes was done as described previously [38]. To 
reduce background hybridization to repetitive regions, all blots were 
subjected to two high-stringency washes of 0.1 X SSC for 40 min at 
68°C. DNA from X cDNA clones was analyzed for cross-hybridization 
to other clones using the same procedure. 
RNA isolation, blotting, and hybridization. Total cellular RNA 
was purified by guanidine-isothiocyanate extraction [39], denatured 
with glyoxal and dimethyl sulfoxide [40], and fractionated by electro- 
phoresis on a 1.2% agarose gel. As a check on the quality and quantity 
of loaded RNA, agarose gels were stained with ethidium bromide and 
the RNA was visualized under uv light before Northern blotting to 
nitrocellulose. Transfer and hybridization were carried out under the 
same conditions as those for Southern blots. After autoradiography, 
RNA levels were quantified by scanning densitometry (Hoefer Scien- 
tific Instruments) and the bands were integrated using a microcom- 
puter. 
Construction of the cDNA library. Total RNA was isolated from 
quiescent late-passage MRC-5 cells (PDL 69). Poly (A)+ RNA was 
then selected from total RNA using oligo d(T) cellulose chromatogra- 
phy. Double-stranded cDNA was made from the senescent cells using 
the method of Davis et al. [41] with the following modifications: (1) no 
radioactive nucleotides were used in synthesis of either strand of the 
cDNA to eliminate possible radiation-induced nicking; (2) cloned 
Maloney murine leukemia virus reverse transcriptase (Bethesda Re- 
search Laboratories) was used for first-strand cDNA synthesis; (3) 
the Klenow fragment of DNA polymerase I was used for second- 
strand synthesis; (4) the cDNA was fractionated on a 1.2% agarose gel 
and visualized by staining with ethidium bromide. 
The cDNA fragments larger than 600 bp were cut out of the gel, 
electroeluted overnight, dialyzed against two changes of 10 mM Tris 
(pH 8.0)/l mM EDTA for 1 h, and precipitated in ethanol. EcoRI 
linkers were added as described [41]. The library was prepared using 
this cDNA and the X Zap vector following the method supplied by 
Stratagene. The initial plating generated 200,000 primary plaques. 
The library was amplified by growing the primary plaques to near 
confluence and then resuspending the phage in buffer 1421. 
Library screening. Both early (PDL27) and late (PDL69) passage 
cells were forced into a quiescent state by growing them to confluence 
and incubating them without subculturing for 7 days. Oligo (dT) col- 
umn-purified mRNA was prepared from the two groups and “‘P-la- 
beled cDNA was synthesized using Maloney murine leukemia virus 
reverse transcriptase (Bethesda Research Laboratories) and random 
oligo primers. The early- and late-passage cDNA probes were then 
used to screen plaques of a senescence-specific cDNA library in A Zap 
1421. To obtain a high probability of detecting prevalent senescence- 
specific mRNAs, ten 15.cm plates with 400 plaques per plate were 
screened. Duplicate nitrocellulose blots were made to each plate and 
hybridized to the early- or late-specific cDNA with the same size and 
specific labeling. After autoradiography for 2 days, plaques corre- 
sponding to senescent-specific signals were selected and phage DNA 
was prepared by standard methods [42]. 
Secondary differential screening was done by dot blot analysis of 
the isolates selected to be senescence-specific in the primary screen- 
ing. Phage clones selected in the secondary screening were digested 
with the restriction endonuclease EcoRI to excise the cDNA inserts 
and were size-fractionated by agarose electrophoresis. The cDNA in- 
serts were isolated by electroelution followed by dialysis and ethanol 
precipitation. 
DNA sequencing and sequence analysis. The largest SAG cDNA 
clone was cleaved into smaller restriction fragments and then ligated 
into M13mp18 or M13mp19 phage. The recombinant phage were 
transformed into JM109 cells, and single-stranded DNA from each 
clone was prepared. Sequencing was carried out by the dideoxy chain 
termination method, using the sequenase 2.0 kit (Stratagene) or the 
kilobase kit (US Biochemical Corp.). Overlapping sequences were de- 
termined for both strands of the DNA. Overlap analysis was done on 
a computer using the Caltech DNasis program to align the sequenced 
fragments. The 1636-bp SAG cDNA sequence was matched against 
GenBank and further analyzed using programs developed by the Ge- 
netics Computer Group. 
RESULTS 
Cloning of genes displaying changes in mRNA abun- 
dance with replicative senescence. Like all normal dip- 
loid fibroblasts, MRC-5 cells, originally derived from 
fetal lung tissue, have a limited life span in culture [43]. 
In nine independent experiments, we found that the 
average PDL limit was 69 +- 4 under our culture condi- 
tions [44]. To identify senescence-specific genes, differ- 
ential hybridization screenings were carried out of ra- 
diolabeled cDNA from early (PDL 27) and late (PDL 
69) passage cells against a X cDNA library prepared 
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FIG. 1. Identification of senescence-specific genes by differential 
screening of a X Zap cDNA library. Two nitrocellulose plaque lifts 
were taken from the same plate containing 400 plaques and were 
hybridized to labeled cDNA from early- or late-passage MRC-5 cells. 
A, B, C, and D label four of the down-regulated isolates. The down- 
ward arrows point to an up-regulated SAG isolate. The rightward 
arrow in the PDL 69 blot points to a false positive. 
from late-passage senescent MRC-5 cells (PDL 69). 
Since we were most interested in isolating genes that 
were not modulated with the cell cycle or the growth 
state of the cells, mRNA was prepared from cells which 
were quiescent following 7 days of confluency. 
Figure 1 shows an example of such a primary differ- 
ential screen. Even though the X library was made from 
mRNA of senescent cells, we consistently found some 
10 times more clones that appeared to be down-regu- 
lated with senescence than those that appeared up- 
regulated (such as the weakly labeled colonies A to D in 
the senescent-probed blot of Fig. 1). In our initial 
screening of 4000 plaques, we isolated 32 clones that 
hybridized strongly to senescent cDNA. These clones 
were amplified and the DNA dot blotted for hybridiza- 
tion to early- and late-passage cDNAs. Eight of these 
clones proved positive again (data not shown). DNA 
was purified from each of the positive isolates. Restric- 
tion analysis showed that four of the clones had a 600- 
bp insert, while a few had larger inserts up to 1.6 kb in 
length (data not shown). The 1.6-kb insert was found to 
strongly cross hybridize to all of the other up-regulated 
isolates (data not shown), indicating that the isolates 
were copies of the same or similar mRNA species. Sup- 
porting this interpretation, the 1.6-kb insert readily de- 
leted to 600 bp if amplified in the X vector. The clone 
bearing the 1.6-kb insert was designated SAG for se- 
nescence-associated gene and was used for all of the 
subsequent analysis. 
SAG expression during replicative senescence. To 
characterize the changes in SAG mRNA levels during 
senescence, equal amounts of total RNA were electro- 
phoretically fractionated from both early (PDL 27) and 
late (PDL 69) passage fibroblasts and hybridized to la- 
beled SAG cDNA after Northern blotting. Figure 2 dem- 
onstrates that SAG hybridizes to a single 2.8-kb band. 
The level of SAG mRNA was threefold higher in late 
relative to early passage MRC-5 cells. As a control for 
RNA loading or degradation artifacts, the Northern 
blot probed with SAG (left side) was washed at 70°C for 
1 h in deionized water to remove all traces of radioactiv- 
ity and reprobed with a 32P-labeled DNA fragment from 
an exon of the retinoblastoma gene (right half of Fig. 2). 
The level of retinoblastoma mRNA has been reported to 
remain nearly constant during the in vitro senescence of 
human fibroblasts [27]. Figure 2 indicates that the level 
of SAG mRNA increases relative to retinoblastoma 
with population doubling. To determine the reproduc- 
ibility of the threefold increase in SAG mRNA levels, 
seven separate Northern blot experiments were carried 
out using total RNA from early- and late-passage cells. 
The level of SAG mRNA was greater in the late-passage 
senescent cells by a factor of 3.0 * 0.3 for the seven 
experiments. 
To determine the developmental progression of SAG 
mRNA during replicative senescence, total RNA was 
prepared from MRC-5 cells at various population dou- 
bling levels and was subjected to Northern blot analysis 
as above. In one such experiment, four identical North- 
ern blots were hybridized to retinoblastoma, cul-colla- 
gen, @-actin, or SAG (Fig. 3). Compared to the near con- 
stant expression of the retinoblastoma and /3-actin 
genes, expression of the collagen (~-1 chain mRNA de- 
creased lo-fold during replicative senescence. In con- 
trast, SAG expression increased with senescence, but 
mainly during the last 20% of the replicative life span. 
To compare the changes in SAG expression to the 
rate of cell proliferation, the Northern blot data from 
three separate experiments were quantitated by densi- 
tometry and the values plotted as a function of the per- 
PDL 
27 69 27 69 
4.7 kb 
SAG Relinoblastoma 
FIG. 2. Expression of SAG and retinoblastoma in early- and 
late-passage MRC-5 cells. Quiescent MRC-5 cells of PDL 27 and 69 
were incubated for 7 days without subculturing. The cells were har- 
vested and total RNA was isolated and analyzed by Northern blot- 
ting. The left side shows the blot hybridized to labeled SAG cDNA. 
The SAG-probed blot was then washed and rehybridized to retinoblas- 
toma cDNA (right side). 
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FIG. 3. Expression profiles of retinoblastoma, Lul-collagen, fl-ac- 
tin, and SAG mRNA during the MRC-5 proliferative life span. For 
each PDL level, MRC-5 fibroblasts were incubated for 7 days after 
quiescence was reached and then harvested. Four duplicate Northern 
blots were hybridized to each of the four probes. Because of RNA 
loading and blotting variations, the SAG mRNA level was abnormally 
high at PDL27 in this blot while the PDL 35 SAG sample was abnor- 
mally low, compared to successively repeated experiments. 
centage of the life span completed. We then plotted the 
time for each population doubling versus the percentage 
of life span completed. Figure 4 demonstrates that 
changes in SAG mRNA closely parallel the rate of cell 
doubling. These results indicate that SAG is an accurate 
positive marker for the decline in fibroblast doubling 
potential. The al-collagen gene is also a good marker, 
although its mRNA expression declines rather than in- 
creases with replicative senescence. 
SAG expression remains unchanged during the cell 
cycle. It has been proposed that postmitotic senescent 
fibroblasts reside in a different part of the cell cycle (the 
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FIG. 4. Enhancement of SAG mRNA expression parallels the 
increase in MRC-5 cell doubling time during replicative senescence. 
The percentage of total life span completed and days per population 
doubling (V) are expressed as mean values from three independent 
experiments. The levels of SAG and al-collagen mRNA were quanti- 
tated by averaging the densitometry scans of three experiments. SAG 
expression was plotted as a percentage of its maximum level found in 
senescent cells, while oil-collagen was plotted as a function of its level 
in early-passage cells. 
FIG. 5. Gene expression following serum induction of quiescent 
early-passage cells. MRC-5 cells (PDL 30) were incubated 72 h in 
medium containing 0.5% serum to induce quiescence. Northern blots 
were prepared using total RNA from cells harvested at 0,0.5,1,1.5,2, 
3,6, and 12 h after serum induction. Identical blots were hybridized to 
labeled probes for retinoblastoma, al-collagen, P-actin, or SAG. On a 
separate blot (last panel), SAG mRNA was further assayed at 2,6,10, 
and 24 h after serum stimulation. DNA synthesis begins some 10 to 18 
h poststimulation [34, 47-483 as confirmed in our cultures by the 
induction of S-specific H4 histone mRNA at 8 to 16 h poststimulation 
(data not shown). 
G,/S boundary) than do quiescent early-passage cells 
[5,45]. To determine whether the levels of SAG mRNA 
reflect cell-cycle changes rather than true senescence, 
RNA was isolated from early-passage cells at different 
points in the cell cycle. MRC-5 cells (PDL 30) were first 
cultured for 72 h in medium containing 0.5% serum to 
induce quiescence. The fibroblasts were then harvested 
at regular intervals after growth stimulation with media 
containing 10% serum. RNA purified from those cells 
was subjected to Northern blotting and then hybridized 
to probes for SAG, retinoblastoma, /3-actin, and al-col- 
lagen. The top two panels in Fig. 5 show that retinoblas- 
toma and al-collagen mRNA levels change little during 
the cell cycle. In contrast, /I-actin expression is strongly 
stimulated by serum, as has been shown previously [46]. 
The last two panels show that the level of SAG mRNA 
does not change significantly in response to serum. 
Moreover, no increase in SAG message is seen in these 
early-passage cells as they traverse the G,/S boundary 
of the cell cycle (Fig. 5, bottom panel, which occurs some 
10 to 18 h after serum stimulation [34,47-481). We con- 
clude that the changes in SAG mRNA levels that occur 
during in vitro culture of MRC-5 cells are not due to 
cell-cycle differences in early- versus late-passage cells. 
These data also indicate that the SAG gene is not serum 
responsive, as are many of the genes involved in growth 
regulation. 
SAG is widely expressed in tumor cell lines. To deter- 
mine whether SAG is expressed in various immortalized 
cells from differing origins, RNA was isolated from 12 
human tumor cell lines, fractionated on agarose gels, 




FIG. 6. SAG expression in various cell lines. SAG expression in 
12 different cell lines was analyzed by Northern blotting as before. 
Since no probe has been identified as a hybridization control for all of 
these polyploid and transformed cell types, quantitation of SAG 
mRNA levels was normalized to the total undegraded RNA loaded in 
each lane. (A) Total RNA was probed from PDL 27 MRC-5, PDL 69 
MRC-5, cervical carcinoma (HeLa), bladder carcinoma (J82), and 
brain glioblastoma (T98G) in lanes l-5. (B) Total RNA was probed 
from PDL 27 MRC-5, PDL 69 MRC-5, colon carcinoma (ATCC CCL 
247), bladder carcinoma (ATCC HTB 9), lung carcinoma 1 (ATCC 
HTB 58), lung carcinoma 2 (ATCC HTB 53), adenovirus-trans- 
formed embryonal kidney (ATCC CRL 1573), breast duct carcinoma 
(T47D), nasal septum carcinoma (ATCC CCL 30), Wilm’s tumor 
(kidney, ATCC CRL 1441), cervical carcinoma (HeLa), and breast 
adenocarcinoma (ATCC HTB 132) in lanes 1-12. The positions of 28 
S rRNA and SAG mRNA are shown on the right. 
and Northern blotted along with RNA from early- and 
late-passage MRC-5 cells. The blots were then hybrid- 
ized to the labeled 1.6-kb SAG cDNA. Figure 6 demon- 
strates that SAG is expressed in all cell lines tested with 
the possible exception of HeLa cells, which have little 
(Fig. 6B) or no (Fig. 6A) expression. 
SAG contains both highly repetitive DNA and low- 
copy, evolutionwily-conserved elements. The require- 
ment for stringent hybridization conditions in order to 
obtain clear Northern blots when probing with SAG 
suggested the presence of repeated elements. To test 
whether SAG contains highly repetitive DNA, duplicate 
Southern blots containing electrophoretically fraction- 
ated human DNA restricted with EcoRl were hybrid- 
ized to radiolabeled SAG DNA (lane H, middle panel of 
Fig. 7) or to a c-fos probe containing an Alu repeat (lane 
H, left panel of Fig. 7). The 1.6-kb SAG clone hybridizes 
very strongly to the full range of fractionated human 
DNA in the same way that the Alu-containing probe 
does. Since AZu is one of the most highly repeated ele- 
ments in the human genome, Fig. 7 indicates that SAG 
contains very highly repetitive DNA. 
To determine whether SAG also contains low-copy 
and evolutionarily-conserved elements, we included rat 
liver DNA on the duplicate Southern blots in Fig. 7 
(lanes R). In contrast to the smeared signal from human 
DNA, hybridization of SAG or c-fos probes to EcoRl-re- 
stricted rat DNA gives rise to single EcoRl bands of 2.5 
or 2.2 kb, respectively, indicating that the unique por- 
tions of SAG are similar to c-fos in copy number and 
conservation. Since the human c-fos gene is known to be 
a single-copy gene with high homology to rat c-fos, these 
data suggest that SAG contains DNA elements that are 
homologous to a single-copy cognate gene in rats. 
To localize the SAG nonrepetitive sequences, various 
radiolabeled fragments of the 1.6-kb SAG clone were 
used to probe Southern blots containing EcoRl-re- 
stricted human DNA. A 232-bp Hue111 fragment at the 
5’ terminus of the SAG cDNA hybridizes to a discrete 
8-kb band (Fig. 7, right panel). A discrete band of the 
same size was also seen after hybridization to a 640-bp 
Hind111 fragment at the 5’ end of the SAG cDNA (data 
not shown), indicating that the first 40% of the SAG 
clone is nonrepetitive. As discussed below, sequencing 
data suggest that this nonrepetitive region coincides 
with the presumed SAG coding sequences. In contrast, 
most of the sequences 3’ of the Hind111 site contain re- 
petitive DNA (data not shown). 
Sequence analysis of the 1.6-kb SAG clone. We made 
three attempts to obtain a full-length cDNA clone of 
SAG by screening two separate cDNA libraries, but 
were unsuccessful. Our lack of success may have been 
due to the tendency for SAG sequences to be deleted 
from bacterial cloning vectors. Since a full-length clone 
was unavailable, we have sequenced the 1.6-kb SAG 
clone by subcloning fragments into single-stranded 
Ml3 (Fig. 8). The coding strand was determined by hy- 
bridizing Northern blots containing fractionated RNA 
from MRC-5 cells with 32P-labeled probes prepared 
from each strand of SAG cDNA in M13mp18. Only the 
complement to the Fig. 8 sequence showed any hybrid- 
ization to SAG mRNA (data not shown), identifying the 
FOS + Au SAG + ALU SAG 
MHR 
FIG. 7. Southern blot analysis of SAG in human and rat genomic 
DNA. Human (lanes H) and rat (lanes R) genomic DNA was re- 
stricted with EcoRl and electrophoresed on a 1% agarose gel as dupli- 
cate sets along with HindIII-restricted X (lane M) as a marker. The 
fractionated DNA was blotted to nitrocellulose and the duplicate sets 
were separated and hybridized to a labeled 2.1-kb P&I-BamHl C-/OS 
probe [38], containing an Ah repeat and the 3’ c-fos coding region 
(left panel), or to the labeled 1.6.kb SAG probe (middle panel). In the 
right panel, a Southern blot containing EcoRl-restricted human 
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GAGTGAGGACCCTGCACAGAGCGGCATGTACATGCATACGAATCGGAGCTCAGCTGATGCCTCTCGCAAGCTGTCAGAGGCTCAGCATTG~AT~T~TAA~ 
CTTGAQCGCAQATTGCATCACQCAGGGGGCTATGGCACAGGQCTGQACAAGTGAQAGACCTCCACTCCTGCAGCAGCCACGGAGAGAGGCTGCGGAA~A 
Exon 1 R WT RPRCCAE 
GAGCTQTQCQTCTMGGTGTCGGGQCCAGAGAQTGTQTCTAGCGCMGACACGTQCACCAATTQTCGGAGCGGTGGACGCGACCGCGGTG~TGTGCAQAG 
R RGQDKVRSDR RRPISQ 
CGGCQTGGACAAGACAAAGTCCGTAGTGACCQGCGGCGTCCAATCAGTCAGTQGGCTCCCGCTTGGGCAGATGGTGCTGAGTGGGGTCGACCACGGTG~T 


















FIG. 8. Nucleotide sequence of the 1.6-kb SAG clone and the predicted C-terminal amino acid sequence of the SAG protein. Three exons 
with excellent protein-coding potential were predicted by GRAIL (Oak Ridge National Laboratories) and the predicted amino acid sequence is 
given for these exons. The single Hind111 site is underlined and labeled. Most the sequences 3’ of exon 3 contain genomic repeated DNA based 
on hybridization data. The Ah consensus sequence starts at sequence 1305 bp and continues until the end of the sequence. 
Fig. 8 sequence as the SAG-coding strand. In searching 
GenBank for homology to SAG, no unique sequence 
with any significant stretch of similarity was identified 
to either the 1.6-kb SAG cDNA or the 640-bp SAG sub- 
clone that does not contain any repetitive elements. 
Thus, SAG appears to be a novel gene. 
Blot and sequence analysis has also demonstrated 
that SAG contains repetitive as well as nonrepetitive 
DNA elements (Fig. 7 and data not shown). A sequence 
comparison with Alu showed that the 3’ end of the SAG 
cDNA contains a stretch of nucleotides of approxi- 
mately 300 bp in length that has 51% homology to a 
human Alu family consensus sequence [49, 501. More- 
over, when the microcomputer program DNasis was 
used to identify stretches of repeated sequences within 
the SAG cDNA, many small internal repeats were 
found. Since repetitive DNA has been associated with X 
clonal instability [36], these internal repeats may have 
contributed to the high deletion rate of SAG sequences 
in commonly used cloning vectors and to our repeated 
lack of success in cloning a full-length copy of SAG 
cDNA. 
SAG has been analyzed for protein-coding potential 
on GRAIL (gene recognition and analysis internet link) 
at Oakridge National Laboratories. The program, which 
is optimized for human codon recognition, detected 
three short exons with an excellent probability of form- 
ing coding regions. These three coding regions appear to 
be separated by introns, suggesting that the 1.6-kb SAG 
fragment is actually an unprocessed mRNA precursor. 
Perhaps the processed SAG cDNA is spontaneously de- 
leted out of the X cloning vector while the rare unpro- 
cessed mRNA is more stable. 
DISCUSSION 
SAG is a novel gene that is up-regulated with 
senescence. By differentially screening a cDNA library 
from senescent MRC-5 fibroblast cells, we have ob- 
served an altered expression of some mRNAs during 
senescence, most of which appear to be down-regulated. 
al-collagen is one such down-regulated gene, while 
many others have been reported in the literature [3, 4, 
341. In contrast, we only observed one cDNA species 
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FIG. 9. Homology of the SAG basic motif to the DNA-binding 
domains in various nuclear regulatory proteins. SAG exon 1 contains 
a basic motif rich in arginine and lysine (R and K residues shown in 
bold) that resembles the basic DNA-binding domains found in many 
nuclear regulatory proteins. E12, E47, MyoDl, and c-jun are all tran- 
scription factors. The antigrowth gene ~53 contains a similar basic 
motif at residues 273-293 [52], in which mutation of the first arginine 
(R2,a) abolishes both antigrowth and DNA-binding activity [53]. 
(SAG) which was up-regulated when comparing quies- 
cent early- and late-passage MRC-5 fibroblasts. Our 
data show an increasing expression of SAG that directly 
parallels the decline in MRC-5 growth potential. Since 
SAG is not cell-cycle regulated, it is one of the first up- 
regulated markers of human fibroblast senescence that 
is unaffected by the cell cycle or the growth state of the 
cell. Blot and sequence analysis of SAG defines a novel 
gene which is widely expressed in many cell types and is 
evolutionarily conserved. However, SAG cDNA also has 
numerous repetitive elements that may generate insta- 
bility on amplification in bacterial vectors. 
SAG may be regulatory. While the possible functions 
of SAG are unknown, three lines of evidence suggest 
that SAG may be of regulatory significance during se- 
nescence. First, the increase in SAG expression shows 
an inverse correlation with the doubling rate of MRC-5 
cells as they are cultured in vitro (Fig. 4). Second, SAG 
mRNA regulation appears to be altered in most immor- 
tal cells, because 10 of 12 immortal cell lines have much 
lower levels of SAG RNA than do late-passage MRC-5 
cells (Fig. 6). Moreover, two human fibroblast cell lines 
transformed by SV40 contained levels of SAG mRNA 
similar to that found in early-passage MRC-5 cells even 
after being cultured for more than 100 doublings (data 
not shown). These data on transformed cells suggest 
that immortalization may uncouple or suppress the up- 
regulation of SAG mRNA as fibroblasts double in cul- 
ture. 
Third and most significant, the C-terminal region of 
the SAG protein (exon 1, Fig. 8) contains a potential 
DNA-binding domain (Fig. 9) with sequence homology 
to the basic domains found in the muscle-determining 
factor MyoDl, the K enhancer-binding proteins El2 and 
E47, and the FoslJun family of protooncogenes [51]. A 
similar basic motif is found in the C-terminal region of 
the p53 antigrowth gene [52] that has been identified as 
one of four conserved hot spots for oncogenic mutations 
[25] and as a required region for DNA binding [53]. 
Taken together, these data suggest that SAG may be a 
regulatory protein. 
Comparison with other reported senescence-specific 
genes. It is of interest to compare SAG with other po- 
tential inhibitory genes which may have a role in control- 
ling senescence. Lumpkin et al. [ll] estimated that the 
RNA species responsible for inhibition of DNA synthe- 
sis in senescent fibroblasts are present at levels 200-fold 
higher in late-passage senescent than in early-passage 
quiescent cells. SAG mRNA only increases threefold 
during senescence. Thus, it is unlikely that SAG could 
be the sole inhibitor, though it is possible that it is one of 
several RNA species needed to inhibit the synthesis 
of DNA. 
A second candidate for a regulator of replicative sene- 
scence has been identified in yeast. Jazwinski’s labora- 
tory [54, 551 has used differential cDNA screening to 
clone genes from senescent yeast cells that are up- or 
down-regulated with replicative age. As in human fibro- 
blasts, differential screening identified many genes 
which were down-regulated with yeast senescence but 
only one (030) was up-regulated. Like SAG, 030 was 
not cell-cycle regulated. 
Finally, anti-proliferation genes have been identified 
on the hamster X chromosome [56], human chromo- 
some 1 [20], and human chromosome 4 [21]. Moreover, 
the insertion of chromosome 4 into HeLa, 582, or T98G 
cell lines, which belong to complementation group B 
[ 191, leads to reversal of the immortal phenotype, while 
other complementation groups are not affected [21]. We 
note that SAG mRNA expression is very low or nonex- 
istent in T98 or HeLa cells and low in 582 cell lines (Fig. 
6A), suggesting a possible correlation with the gene(s) 
on chromosome 4. 
While both increases and decreases in specific mRNA 
levels could contribute to replicative senescence, recent 
data suggest that the senescence phenotype is domi- 
nant, so that genes with increasing expression may be of 
greater relevance. SAG’s pattern of expression and its 
potential DNA-binding domain are consistent with the 
notion that replicative senescence is under dominant 
genetic control. Thus, a better understanding of SAG 
regulation may help elucidate the genetic mechanism of 
replicative senescence. 
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